All G Self-Affirms GRAS Status for Its Precision-Fermented Human Lactoferrin as FDA Weighs Ending Self-Affirmation

Australian biotech All G says it has self-affirmed Generally Recognized as Safe status in the U.S. for a human lactoferrin made by precision fermentation, for adult nutrition and supplements, while FDA's proposal to require GRAS notifications is open for comment until Dec. 9.

All G, a Sydney biotech company, has self-affirmed Generally Recognized as Safe (GRAS) status in the U.S. for a recombinant human lactoferrin made by precision fermentation, vegconomist and Green Queen reported on Nov. 18. The company says the protein can now go into adult nutrition and supplement products. The self-affirmation does not cover infant formula.

TLDR

  • Lactoferrin is an iron-binding protein found in breast milk. All G makes a recombinant version of the human protein using microbes.
  • The GRAS status is self-affirmed. Green Queen reported that a separate GRAS filing and more safety data would be needed for infant formula.
  • All G’s bovine lactoferrin received an FDA no-questions letter in April 2026.
  • FDA has proposed making GRAS notifications mandatory, with comments due Dec. 9.

What All G Announced

All G says its human lactoferrin matches the breast milk protein in a four-amino-acid cluster tied to its bacteria- and cell-binding activity, and in keeping iron saturation low. Green Queen reported 4% iron saturation, reached during fermentation. All G also says the protein is not a cow’s milk allergen.

The company reported in-house tests against a commercially available human lactoferrin that it did not name. The two outlets gave different figures for the results, so they are not repeated here. All G said further trials are underway. Human and bovine lactoferrin share about 70% of their amino acid sequence.

The Company So Far

All G began U.S. sales of its bovine lactoferrin four months earlier, vegconomist reported. Green Queen reported that the company has raised $36 million to date and is fundraising. In December 2025, All G formed a joint venture, vegconomist reported, with French ingredients supplier Armor Protéines to commercialize lactoferrin. The company is also developing human caseins and alpha-lactalbumin, with the stated goal of an infant formula made entirely from human milk proteins.

Self-Affirmed GRAS Under Review

Under current rules, a company can conclude on its own that an ingredient is GRAS without notifying FDA. In a proposed rule published Aug. 11, 2026, FDA proposed requiring GRAS notices for substances used in human or animal food. Comments close Dec. 9, 2026. Neither outlet said whether All G has notified FDA of its human lactoferrin determination.

Why It Matters

Precision-fermented milk proteins are reaching the U.S. market through the GRAS pathway that FDA has proposed to tighten. If the rule is finalized as proposed, self-affirmed ingredients such as this one would need to go through FDA notification. All G’s next step, infant formula, already requires a separate GRAS filing and additional safety data.


Sources: vegconomist (Nov. 18, 2026); Green Queen (Nov. 18, 2026); Federal Register, Aug. 11, 2026.